Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
9.70
-0.76 (-7.27%)
At close: May 26, 2026, 4:00 PM EDT
9.77
+0.07 (0.72%)
After-hours: May 26, 2026, 7:59 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $86.19 million as of May 26, 2026. Its market cap has increased by 468.21% in one year.
Market Cap
86.19M
Enterprise Value
76.19M
1-Year Change
468.21%
Ranking
Category
Stock Price
$9.70
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $86.19M, an increase of 132.20%. That is a compound annual growth rate of 12.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 92.94M | 685.40% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Q32 Bio | 98.35M |
| LeonaBio | 97.04M |
| Rein Therapeutics | 95.83M |
| PolyPid | 95.80M |
| Annovis Bio | 94.87M |
| Oncolytics Biotech | 94.01M |
| Anixa Biosciences | 93.54M |
| Aldeyra Therapeutics | 93.50M |